Uro-Q Sustained Release Tablet 4 mg (Tolterodine L-Tartrate)

Adult dose

Adults: Take 4 mg of tolterodine L-tartrate orally once daily. Patients with renal impairment, hepatic impairment, or those receiving ketoconazole or another potent CYP3A4 inhibitor: Take 2 mg of this drug once daily. If adverse reactions occur, the dose may be reduced from 4 mg to 2 mg once daily. This drug may be taken with or without food. Swallow the dosage form whole; do not crush or split it.

This drug is used to control hyperreactivity of the bladder. This drug should not be used in patients with urinary retention symptoms, gastrointestinal obstruction, uncontrolled glaucoma, severe myasthenia gravis, severe ulcerative colitis, or toxic megacolon. Patients at risk of urinary retention or those with gastrointestinal obstruction diseases, renal and liver function impairment, or autonomic neuropathy should use this medication cautiously. Also, caution is needed when used in combination with certain antibiotics, antifungals, and immunosuppressants. This medication may cause various side effects such as dry mouth, dyspepsia, constipation, drowsiness, dizziness, headache, and difficulty urinating; therefore, if unusual symptoms occur, consult a healthcare professional immediately. There is a risk of heart problems related to QT interval prolongation, so patients with heart diseases should be particularly careful, and it should be avoided when taken with potent CYP3A4 inhibitors. Care is needed when driving or operating machinery, and the cause of bladder problems should be accurately identified before treatment. This medication may enhance the effects when taken with other antimuscarinic drugs, and there may be interactions with some medications, so if you are taking other medications, you should inform your doctor. It is advisable that pregnant or breastfeeding women not use this medication, and women who may become pregnant should use it with appropriate contraception. Safety and efficacy in children have not been sufficiently established. In case of overdose, serious side effects such as vision impairment and difficulty urinating may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and it is advisable to avoid transferring it to another container.

• Dry mouth
• dyspepsia
• decreased tearing
• bronchitis
• allergic reactions
• confusion
• drowsiness
• dizziness
• headache
• nervous hypersensitivity

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is preferable to store it at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medication for a longer period.

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle